Newborn Jaundice - An Investigation of Different Approaches to Light Therapy

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2029

Conditions
Neonatal Hyperbilirubinemia
Interventions
OTHER

Continuous Phototherapy with a irradiance of 40 µW/cm2/nm from the overhead light

The difference in irradiance between the groups will be measured with a radiometer specific to the device's wavelength.

OTHER

Continuos Phototherapy with a irradiance of 55 µW/cm2/nm from the overhead light

The difference in irradiance between the groups will be measured with a radiometer specific for the device's wavelenght

OTHER

Continuous Phototherapy with a irradiance of 70 µW/cm2/nm from the overhead light

The difference in irradiance between the groups will be measured with a radiometer specific for the device's wavelenght

OTHER

Cycled phototherapy with a irradiance of 70 µW/cm2/nm from the overhead light

The difference in irradiance between the groups will be measured with a radiometer specific for the device's wavelenght

Trial Locations (2)

9000

Aalborg University Hospital, The Neonatal Department, Aalborg

9800

The North Denmark Regional Hospital, The Pediatric Department, Hjørring

All Listed Sponsors
collaborator

Aalborg University Hospital

OTHER

lead

Regionshospital Nordjylland

OTHER_GOV

NCT06702241 - Newborn Jaundice - An Investigation of Different Approaches to Light Therapy | Biotech Hunter | Biotech Hunter